Advertisement

Topics

Merck Announces Final Results of Any and All Tender Offers

06:55 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today the final results of the previously announced offers to purchase (collectively, the “Offers”) any and all of the outstanding notes listed i...

Other Sources for this Article

Merck
Media:
Claire Gillespie, 267-305-0932
or
Investors:
Amy Klug, 908-740-1898

NEXT ARTICLE

More From BioPortfolio on "Merck Announces Final Results of Any and All Tender Offers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...